Trial Profile
A Phase I, Open-Label, Randomized, Crossover Trial in Healthy Subjects Receiving DRV Combined With RTV Low Dose to Compare the Oral Bioavailability of DRV Suspension to That of DRV 300 mg Tablet Under Fasted and Fed Conditions, and to Assess Multiple Dose Pharmacokinetics of the DRV Suspension.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- 12 Sep 2009 Results were presented at ICAAC 2009.
- 29 Sep 2008 New trial record.